The CDCC is pleased to solicit applications for its Rapid Research Pilot Program to provide support for small, manageable research studies.
Donor Name: Coordination and Data Collection Center (CDCC)
State: All States
County: All Counties
Territory: Commonwealth of Puerto Rico, U.S. Virgin Islands, Guam, American Samoa and the Commonwealth of the Northern Mariana Islands
Type of Grant: Grant
Deadline: 08/26/2022
Size of the Grant: $200,000
Grant Duration: 1 year
Details:
Purpose
Evaluation of established as well as new diagnostic tests and their ultimate implementation by communities adversely affected by COVID-19 is critical to reducing the disease burden in the US. Clinicians, the public health community, advocates, policymakers, and the public require reliable, accurate information regarding the accessibility and effective utilization of COVID-19 diagnostic tests in underserved populations.
Project Objectives and Scope
They anticipate that new tests and testing modalities will become available over the course of the RADx-UP initiative. This Rapid Research Pilot Program is intended to provide an expedited mechanism to assess the feasibility of integrating novel or emerging technologies into RADx-UP in coordination with the NIH-supported RADx initiatives. Applicants should address a number of potential challenges including the following three (3) key areas:
- Potential barriers to effective testing should be identified and addressed. Specific barriers may include:
- Requirement of self-collection and self-administered testing versus the availability of a health professional for collection
- Limited health literacy and ability to understand and interpret test methods, results, and follow up recommendations.
- Secured return of test results and a requirement of online or digital delivery of test results
- Test costs and reimbursement
- Alignment of the testing to the target population, or: is the test method appropriate, accounting for the interests, needs, and beliefs of the underserved community?
- Testing workflow and access. Are the tests administered in or outside the home? Are the tests scalable in terms of testing supplies shelf life, storage conditions, and vendor inventories?
The goal of the program is to improve access to and uptake of diagnostic COVID-19 testing in communities of underserved and vulnerable populations and to better understand factors that have led to the disproportionate impact of COVID-19 on these groups, and develop interventions to reduce those disparities.
The CDCC Rapid Research Pilot Program seeks an applicant pool that draws from the rich diversity of communities, populations, and groups in the U.S including the U.S. territories, tribal nations or organizations (American Indians, Alaska Natives, Native Hawaiians, and Other Pacific Islanders).
Funding Information
Researchers seeking funds to conduct COVID-19 testing can apply for up to $200,000 in direct cost funding and, if awarded, will have one year to complete the community-engaged NIH-funded RP2 research project.
Eligibility Criteria
Eligible organizations are institutions of higher education, industry, state and local governments, and community-based organizations that have the infrastructure to manage such funding. Historically black colleges and universities (HBCUs), tribally controlled colleges and universities (TCCUs), Hispanic-serving institutions, and other minority-serving institutions are encouraged to apply. They are particularly interested in receiving proposals developed jointly with community-based organizations and encourage partnerships across these different types of organizations to form interdisciplinary teams, including public-private partnerships. Applications with multiple PIs (“co-PIs”) must identify one PI as the main contact PI, with primary responsibility for the administrative aspects of the pilot subaward.
For more information, visit CDCC.
